http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1309623-A2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fddc3a6775379986d5810915b2d059ce |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705 |
classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 |
filingDate | 2001-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9472f8ae727b826bdfd5c8a1bdf2876 |
publicationDate | 2003-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-1309623-A2 |
titleOfInvention | G protein-coupled receptors from human clone "26908" and uses thereof |
abstract | The invention provides isolated nucleic acids molecules, designated 26908 nucleic acid molecules, which encode novel G-protein coupled receptor family members. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 26908 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 26908 gene has been introduced or disrupted. The invention still further provides isolated 26908 proteins, fusion proteins, antigenic peptides and anti-26908 antibodies. Diagnostic methods utilizing compositions of the invention are also provided. |
priorityDate | 2000-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1403.